We are pleased to welcome @Lara Zibners, MD as an Advisor to Cern.

Dr. Zibners is Co-Founder and Chairman of Calla Lily Clinical Care and a long-time advocate for innovation in women’s health. As a physician and entrepreneur operating across the U.S. and Europe, she brings a global lens to commercialization strategy and platform growth.

The women’s health medical device ecosystem is collaborative and interconnected. Over the past several years, our leadership teams have shared insights on what it truly takes to build companies from the ground up and bring meaningful technologies to market.

We look forward to working together as Cern advances its light-based, non-hormonal women’s health platform.

More News

24 April 23

Cern recognised by LARTA Institute

Cern Corporation, (The Cern Device™) is being recognized as one of nine cutting-edge companies that are transforming the healthcare industry. (HEAL....

08 August 24

awaards

OctaneOC Cern Best of Medtech 2024

Cern Corporation has been selected as a finalist for OctaneOC’s prestigious “Best Innovation in Medtech / Device” category ✨ Tech Innovators,...

13 June 23

Cern Logo

Team Cern Expanding – Key Roles

Cern Corporation – Developing a much-needed, non-drug therapy, for mitigation of yeast & bacterial vaginosis (without the need for drugs), is...